Koers Ampliphi Biosciences Corp OTC Bulletin Board
Aandelen
APHB
US03211P1030
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2024 * | 4,54 mln. 4,18 mln. | Omzet 2025 * | 2,75 mln. 2,53 mln. | Marktkapitalisatie | 93,64 mln. 86,17 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -72 mln. -66,25 mln. | Nettowinst (verlies) 2025 * | -67 mln. -61,65 mln. | EV/omzet 2024 * | 20,6 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 34,1 x |
K/w-verhouding 2024 * |
-1,36
x | K/w-verhouding 2025 * |
-1,99
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 29,72% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Deborah Birx
CEO | Chief Executive Officer | 68 | 11-07-23 |
Mina Pastagia
CTO | Chief Tech/Sci/R&D Officer | - | 26-10-20 |
Bryan Kadotani
PRN | Corporate Officer/Principal | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 64 | 12-02-20 | |
Joseph Patti
BRD | Director/Board Member | 60 | 09-05-19 |
Jules Haimovitz
BRD | Director/Board Member | 73 | 01-04-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+33,63% | 50,93 mld. | |
-0,09% | 42,12 mld. | |
+49,62% | 42,05 mld. | |
-4,96% | 29,18 mld. | |
+11,18% | 26,02 mld. | |
-21,95% | 18,9 mld. | |
+8,61% | 13,21 mld. | |
+28,31% | 12,16 mld. | |
+24,73% | 12,17 mld. |
- Beurs
- Aandelen
- Koers ARMP
- Koers APHB